Shahrzad Rafati to give Keynote Address at IBC2016 Conference
IBC announced today that Shahrzad Rafati, Founder & CEO of BroadbandTV, will deliver a keynote on Saturday 10 September at its forthcoming IBC2016 Conference.
Over the last 11 years BroadbandTV has become a powerful force in online video, and is the world’s largest Multi-platform Network. Built on technological expertise, Vancouver-based BBTV represents 16.2 bn monthly impressions with over 76,000 online video creators, providing a full suite of services and solutions including content distribution, technology, promotion, production, creative and design services, and monetisation opportunities in addition to niche value propositions for creators within each of its verticals.
BBTV also offers rights management services for media giants including the NBA, Viacom, Sony Pictures and FremantleMedia. Shahrzad, is an advocate of positive social change and a champion of entrepreneurism.
Shahrzad will talk about how BBTV is working across platforms and creating novel partnerships like the one with AOL’s Huffington Post to create a new kind of online video journalism network called Outspeak and NBA Playmakers, a groundbreaking community for video creators focused on basketball and basketball culture, in partnership with the NBA. She will also talk about how the younger YouTube generation interacts with technology and content and what this means for traditional broadcasting.
Entitled “Transformation in the Digital Era: Leadership, strategy and creativity in media and entertainment”, the conference will see more than 300 executives sharing insights on key issues at the heart of the entertainment, media and technology sector.
Additional information for editors:
The BroadbandTV network has amassed over 76,000 creators, who post about 500,000 new videos per month. It achieves 16.2 bn monthly impressions – making it the largest and fastest growing Multi-Platform Network (MPN) in the world.
In addition to BroadbandTV achievements, Shahrzad is the co-founder of the world’s first Chopra Yoga in partnership with Dr. Deepak Chopra and has investments in a broad portfolio of businesses.
Registration for IBC2016 is now open, with Early Bird discounts on all conference passes available until 15 July at IBC.org/register
## ENDS ##
IBC is the premier annual event for professionals engaged in the creation, management and delivery of entertainment and news content worldwide. Attracting 55,000+ attendees from more than 170 countries, IBC combines a highly respected and peer-reviewed conference with an exhibition that exhibits more than 1,600 leading suppliers of state of the art electronic media technology and provides unrivalled networking opportunities.
BroadbandTV is an innovative media and technology company that drives success for online video creators by leveraging its premium media brands, proprietary technology, and massive online reach. BroadbandTV operates the world’s largest Multi-Platform Network with over 76,000 network partners amassing 16.2 bn views per month. Its content creators span a number of key media brands including: TGN, the largest and most engaged gaming network on YouTube; Opposition, the largest hip-hop music network; number one Electronic Dance Music (EDM) network, WIMSIC; leading kids and family network, HooplaKidz and Outspeak, the next-generation citizen journalism brand in partnership with The Huffington Post. The business recently unveiled Windfall, a joint venture to find, develop and service music artists across all platforms, in partnership with BMG, and NBA Playmakers, a strategic partnership with the NBA to find, discover and develop creators focused on basketball culture. BroadbandTV has developed some of the most advanced and innovative technologies in the online video space: VISO NOVI, for detecting and managing fan uploaded content and VISO Catalyst for enhancing viewership and engagement for premium videos. In June 2013, the leading European entertainment network RTL Group acquired a majority stake in BroadbandTV. Both companies also formed an ongoing strategic partnership to accelerate the global growth strategy of BroadbandTV. RTL Group’s initial investment of US $36m is part of a planned series of investments in the company. Find out more at www.bbtv.com
Conference: 8 - 12 September 2016
Exhibition: 9 - 13 September 2016
For more information visit IBC.org
Liz Cox, Bubble & Squeak
T: 07981 472844
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i